Skip to content

Clinical trials

Phase 3 Hemorrhage trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20073
20091
20142
20152
20171
20202
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
University Hospital, Brest3
Idorsia Pharmaceuticals Ltd.2
Pfizer2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Boehringer Ingelheim1
Centre Hospitalier Départemental1
SFJ Pharmaceuticals, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage18
Hemophilia A2
Hemophilia B2
Stroke2
Subarachnoid Hemorrhage2
Aortic Valve Disease1
Autoimmune Diseases1
Blood Platelet Disorders1
Cataplexy1
Craniocerebral Trauma1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.